GSK plc GSK
NYSE GSK
$46.50 -0.02 (-0.04%)
At close: Oct 9, 2026 · 4:00 PM EDT

Gsk (GSK) Finished Goods (2009 - 2015)

Updated

Gsk's Finished Goods was $2.33 billion in the quarter ended Dec 31, 2014, down 4.9% from $2.45 billion a year earlier.

Analysis

Gsk (GSK) Finished Goods (2009 - 2015) Analysis & Trends

  • In earlier years, Finished Goods was $2.45 billion in the year ended Dec 31, 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn
10 Gsk 100.33 Bn 81.91 Bn 8.24 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 21.50 Bn
Sep 30, 2015 16.13 Bn
Jun 30, 2015 5.42 Bn
Dec 31, 2014 2.33 Bn
Dec 31, 2013 2.45 Bn
Mar 31, 2011 1.96 Bn
Mar 31, 2010 2.02 Bn
Mar 31, 2009 1.94 Bn
API Access

Gsk Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=GSK&period=max&api_key=YOUR_API_KEY